Investigation of the Effect of Macitentan on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Male Subjects

被引：0
|
作者：
Patricia N. Sidharta
Hartmut Dietrich
Jasper Dingemanse
机构：
[1] Actelion Pharmaceuticals Ltd,Department of Clinical Pharmacology
[2] ClinPharmCologne,undefined
[3] MEDA Manufacturing GmbH,undefined
来源：
Clinical Drug Investigation | 2014年 / 34卷
关键词：
Warfarin; Pulmonary Arterial Hypertension; International Normalise Ratio; Dabigatran; Rivaroxaban;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：545 / 552
页数：7
相关论文
共 50 条
  • [31] Effect of exenatide on the pharmacokinetics and pharmacodynamics of warfarin in healthy Asian men
    Soon, Danny
    Kothare, Prajakti A.
    Linnebjerg, Helle
    Park, Soomin
    Yuen, Eunice
    Mace, Kenneth F.
    Wise, Stephen D.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (10): : 1179 - 1187
  • [32] EFFECT OF MORICIZINE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF WARFARIN IN HEALTHY-VOLUNTEERS
    BENEDEK, IH
    KING, SYP
    POWELL, RJ
    AGRA, AM
    SCHARY, WL
    PIENIASZEK, HJ
    JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 32 (06): : 558 - 563
  • [33] Study of the effect of miglitol on the pharmacokinetics and pharmacodynamics of warfarin in healthy males
    Schall, R
    Muller, FO
    Hundt, HKL
    Duursema, L
    Groenewoud, G
    Middle, MV
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1996, 46 (01): : 41 - 46
  • [34] Effect of Macitentan on the Pharmacokinetics of the Breast Cancer Resistance Protein Substrates, Rosuvastatin and Riociguat, in Healthy Male Subjects
    Dénes Csonka
    Shirin Bruderer
    Armin Schultz
    Marianne Soergel
    Radka Stepanova
    Giancarlo Sabattini
    Juan Jose Perez-Ruixo
    Clinical Drug Investigation, 2019, 39 : 1223 - 1232
  • [35] Tegaserod does not significantly affect the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
    Ledford, P
    On, N
    Ligueros-Saylan, M
    Campestrini, J
    Osborne, S
    GASTROENTEROLOGY, 2000, 118 (04) : A1184 - A1184
  • [36] Muraglitazar does not alter the pharmacokinetics and pharmacodynamics of concomitantly administered warfarin in healthy subjects
    Swaminathan, A
    Frost, C
    Nepal, S
    Raymond, R
    Reitberg, D
    Reeves, R
    Mosqueda-Garcia, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P81 - P81
  • [37] Effect of rifampicin on the pharmacokinetics and pharmacodynamics of ticagrelor in healthy subjects
    Renli Teng
    Patrick Mitchell
    Kathleen Butler
    European Journal of Clinical Pharmacology, 2013, 69 : 877 - 883
  • [38] Effect of voriconazole on the pharmacokinetics and pharmacodynamics of zolpidem in healthy subjects
    Saari, Teijo I.
    Laine, Kari
    Leino, Kari
    Valtonen, Mika
    Neuvonen, Pertti J.
    Olkkola, Klaus T.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (01) : 116 - 120
  • [39] Effect of rifampicin on the pharmacokinetics and pharmacodynamics of nateglinide in healthy subjects
    Niemi, M
    Backman, JT
    Neuvonen, M
    Neuvonen, PJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (04) : 427 - 432
  • [40] Effect of menthol on the pharmacokinetics and pharmacodynamics of felodipine in healthy subjects
    Gelal, A
    Balkan, D
    Ozzeybek, D
    Kaplan, YC
    Gurler, S
    Guven, H
    Benowitz, NL
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 60 (11) : 785 - 790
12345